Expert board: "Possibilities of etiotropic therapy for respiratory infections caused by RNA viruses"

On April 26, 2021, in Moscow, under the auspices of the consortium of the academic community for the study of coronavirus infection, an expert council of the Russian Scientific Medical Society of Physicians was held dedicated to modern aspects of etiotropic therapy for the new coronavirus infection and other diseases caused by RNA viruses.

Summary report on results of clinical trial of medicinal product Areplivir

Open randomized multicenter comparative study on the efficacy and safety of AREPLIVIR film-coated tablets (PROMOMED RUS LLC, Russia) in patients hospitalized with COVID-19